Although serum tumor biomarkers alpha-fetoprotein (AFP), carbohydrate antigen 19–9 (CA19–9) and carcinoembryonic antigen (CEA) have been used in digestive cancer risk prediction, the prediction efficiency remains unsatisfactory. Here, CEACAM5 is linked to neoplasm.